User profiles for STEVEN K. LIBUTTI

Steven Libutti

Rutgers University
Verified email at cinj.rutgers.edu
Cited by 27624

von Hippel-Lindau disease

…, GM Glenn, MC Walther, EY Chew, SK Libutti… - The Lancet, 2003 - thelancet.com
von Hippel-Lindau disease is a heritable multisystem cancer syndrome that is associated with
a germline mutation of the VHL tumour suppressor gene on the short arm of chromosome …

Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine

SK Libutti, GF Paciotti, AA Byrnes, HR Alexander Jr… - Clinical cancer …, 2010 - AACR
Purpose: A novel nanomedicine, CYT-6091, constructed by simultaneously binding recombinant
human tumor necrosis factor alpha (rhTNF) and thiolyated polyethylene glycol to the …

Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism

…, JR Shapiro, E Loring, C Nelson-Williams, SK Libutti… - Nature …, 2013 - nature.com
Adrenal aldosterone-producing adenomas (APAs) constitutively produce the salt-retaining
hormone aldosterone and are a common cause of severe hypertension. Recurrent mutations …

Pulsed-high intensity focused ultrasound and low temperature–sensitive liposomes for enhanced targeted drug delivery and antitumor effect

…, M Angstadt, M Bur, J Poff, J Xie, SK Libutti… - Clinical cancer …, 2007 - AACR
Purpose: To determine if pulsed-high intensity focused ultrasound (HIFU) could effectively
serve as a source of hyperthermia with thermosensitive liposomes to enhance delivery and …

A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors

…, KA Edgemon, D Lorang, SK Libutti… - Proceedings of the …, 2001 - National Acad Sciences
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant cancer syndrome,
characterized primarily by multiple tumors in the parathyroid glands, endocrine pancreas, and …

Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes

…, JM Ward, J Lee, Y Hu, HR Alexander, SK Libutti… - Cancer research, 2001 - AACR
We have demonstrated previously the oncolytic effects of a systemically delivered, replicating
vaccinia virus. To enhance the tumor specificity of this vector, we have developed a …

[PDF][PDF] Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal …

AL Feldman, SK Libutti, JF Pingpank, DL Bartlett… - Journal of Clinical …, 2003 - Citeseer
Purpose: Malignant mesothelioma (MM) arising in the peritoneal cavity is a rare neoplasm
characterized by peritoneal progression and for which there are limited therapeutic options. …

MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer

…, A Shai, MG Chun, Y Wang, SK Libutti… - Genes & …, 2009 - genesdev.cshlp.org
While altered expression of microRNAs (miRs) in tumors has been well documented, it
remains unclear how the miR transcriptome intersects neoplastic progression. By profiling the …

Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine tumors (PNETs)

…, GM Glenn, L Middelton, WM Linehan, SK Libutti - Surgery, 2007 - Elsevier
BACKGROUND: von Hippel-Lindau (vHL) disease is an autosomal dominant syndrome
associated with neoplasms in multiple organs, which includes the pancreas. Here, we report the …

The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors

…, RM Minter, TC Lairmore, JF Tseng, HJ Zeh, SK Libutti… - Pancreas, 2020 - journals.lww.com
This manuscript is the result of the North American Neuroendocrine Tumor Society consensus
conference on the surgical management of pancreatic neuroendocrine tumors from July …